Maximus is a telehealth hormone-optimization platform for men, organized around named protocols rather than an open-ended clinical relationship. Protocols run $150 to $300 or more a month, with the initial assessment and lab work usually billed separately. A realistic first year lands near $2,000 to $4,000 including follow-up labs.
Its enclomiphene protocol is why most buyers arrive. Enclomiphene is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus. LH and FSH rise, and the testes produce more testosterone themselves rather than receiving it from outside the body. Sperm production and testicular volume are preserved, which exogenous testosterone does not manage.
Men look for an alternative for two main reasons: they are not eligible for the mechanism, or they need scope the platform does not carry. Six options are listed alphabetically below, with Maximus as a baseline row and the same criteria applied to every row.
The Verdict
Why men look for a Maximus alternative
Four gaps account for most of it, and the first is not about the product at all.
- Eligibility for the mechanism. Enclomiphene raises testosterone by signalling the testes. That requires testes capable of responding. Where LH is already elevated and testosterone remains low, the signal is being sent and not answered, and a different approach is needed.
- Panel breadth. Maximus is hormone-first and protocol-specific. It does not cover the general biomarker set, so lipids, inflammation, and nutrient status sit outside the product.
- Prescription range. Care is organized around named protocols rather than an open list, so peptides, GLP-1s, and ancillary medications are outside the usual scope.
- Cost structure. The monthly protocol figure excludes the initial assessment and the labs. Buyers who want the panels inside a single membership fee are looking at a different pricing model.
Every Maximus alternative, compared
Listed alphabetically, with Maximus as the baseline row. A physician visit is included because fertility questions often belong with a specialist rather than a platform.
| Option | Entry price | Panel scope | Prescriber included | Fertility-preserving option | What it does differently | Best fit |
|---|---|---|---|---|---|---|
| Function Health | $499/yr | 100+ markers, two draws a year | None, add-on review only | No | Finds what a hormone panel leaves out | Men whose symptoms have never been worked up broadly |
| Hone Health | ~$540 to $2,640/yr | Hormone-focused, limited | Telehealth clinician | Testosterone-first; enclomiphene must be requested | At-home finger-prick collection, no lab visit | Men who want testosterone managed at a fixed monthly cost |
| Lifeforce | ~$1,900/yr membership | ~40 markers plus expanded hormones | Nurse practitioner, telehealth | Case by case via the prescriber | Adds thyroid, lipids, and metabolic markers around the hormones | Men who want hormones inside a broader panel |
| Marek Health | $2,500 to $6,000+/yr all-in | A la carte, buyer-selected | Physician plus a coach | Yes, protocols built per client | Retests every 8 to 12 weeks with a deep lab menu | Men running peptides or ancillaries alongside therapy |
| Maximus (baseline) | $150 to $300+/mo plus labs | Hormone-focused, protocol-specific | Telehealth physician | Yes, a standard protocol option | The product every row here is measured against | Men who want testosterone raised without suppressing fertility |
| Opt Health | ~$3,000/yr | 55+ markers | Physician, telehealth | Case by case via the prescriber | Physician-led with at-home draws and a wider panel | Men who want hormones handled inside a wider program |
| Your own physician or a urologist | Copay to a few hundred dollars | Whatever is ordered | Yes, and holds your full history | Yes, if the physician prescribes it | Can order a semen analysis, which no platform does | Men for whom fertility is the actual clinical question |
What each alternative does differently
Function Health
Function Health measures 100-plus markers across two draws a year for $499, with no clinician and no prescribing. It replaces nothing about an active protocol. It appears here because a protocol-specific panel is not built to separate low testosterone from the conditions that imitate it. Thyroid function, ferritin, fasting insulin, and hs-CRP all appear on a broad panel, and any of them can explain the symptoms that lead men to a hormone platform. As a step before treatment it is the cheapest broad baseline available.
Hone Health
Hone Health is the lower-cost telehealth option. An at-home finger-prick kit removes the lab visit entirely, results return 5 to 7 days after the sample arrives, and a telehealth clinician reviews candidacy. Entry sits near $45 a month, and an active protocol including medication runs $150 to $220 or more monthly with quarterly retesting. Prescribing is testosterone-first, and enclomiphene or HCG must be requested rather than being the default. The panel is hormone-focused and limited. The head-to-head is covered in Maximus vs Hone Health.
Lifeforce
Lifeforce widens the panel while keeping a prescriber attached. Roughly 40 markers including expanded hormones, thyroid, lipids, and metabolic values run twice a year inside a membership of about $349 for the first month and $129 monthly after. Care is nurse-practitioner-led with a coaching layer. Prescribing covers hormone therapy, peptides, and GLP-1 medications, billed separately, and fertility-preserving approaches are handled case by case rather than as a named protocol. Semi-annual testing is the slowest cadence here.
Marek Health
Marek Health is the depth option. Labs come from an a la carte menu drawn at a partner lab, a physician owns the prescribing, and a separate coach works through results between physician touchpoints. Retesting runs every 8 to 12 weeks during active titration. The prescription list covers testosterone, select peptides, and ancillaries including aromatase inhibitors and HCG where clinically indicated, which is the route by which fertility preservation is handled. All-in cost lands between $2,500 and $6,000 a year because you control lab volume.
Opt Health
Opt Health handles hormones inside a wider program. Membership near $3,000 a year covers a 55-plus marker panel, at-home phlebotomy, physician-led telehealth, and prescribing across hormones, peptides, GLP-1s, and supplements. Reassessment runs every 3 to 4 months. Against Maximus the gains are panel breadth, a home draw, and a prescription list not bounded by named protocols. The cost is roughly $1,000 more a year at the midpoint, and the panels are included rather than billed separately. The head-to-head is covered in Opt Health vs Maximus.
Your own physician or a urologist
A specialist is the alternative that matters most when fertility is the actual question. A urologist or reproductive endocrinologist can order a semen analysis, which measures sperm concentration and motility directly rather than inferring fertility from LH and FSH. No telehealth platform on this list offers one. A primary care visit is also the cheapest route to a baseline when insurance covers the draw, and it produces something no platform holds, which is your full medical history in one record. The limits are real: insurers often will not cover a full hormone panel without a documented indication.
How to pick a replacement
Four questions, in order. Price is last, because it only separates options doing the same job.
- Do you know your baseline LH and FSH? If not, that measurement comes before any platform decision, because it determines whether the enclomiphene mechanism is available to you at all.
- Is fertility the outcome you care about? If yes, a urologist who can run a semen analysis measures it directly. A hormone platform infers it.
- Do you need scope beyond hormones? Peptides and ancillaries point at Marek Health or Opt Health. A general panel points at Lifeforce or Opt Health, listed alphabetically.
- How fast does your dose need to move? Marek Health panels every 8 to 12 weeks. Opt Health every 3 to 4 months. Hone Health quarterly. Lifeforce semi-annually.
Applying the same ten-criteria rubric across every platform on this site surfaces a pattern that pricing pages hide. Two programs can sit within a few hundred dollars of each other on annual cost and still be different products, because the rows that separate them are who owns the prescription and how many weeks pass before the next panel confirms a change. On this particular comparison a third row matters more than either: whether the underlying mechanism is available to the patient at all.
Which alternative fits which situation
| Your situation | Where to look | Why |
|---|---|---|
| "Fertility is why I chose Maximus and I want a second opinion." | A urologist or reproductive endocrinologist | A specialist can order a semen analysis, which measures the outcome directly rather than inferring it from LH and FSH. No telehealth platform on this list offers one. |
| "My LH came back high and enclomiphene was ruled out." | Hone Health, Marek Health, or Opt Health (alphabetical) | High LH with low testosterone points at primary hypogonadism, where the testes are not answering the signal. Enclomiphene has little to work with, so the options are the platforms that prescribe testosterone directly. |
| "I want a fixed monthly bill with labs included." | Lifeforce or Opt Health (alphabetical) | Both include their panels in the membership. Maximus bills labs and the initial assessment separately, so the monthly figure is not the whole cost. |
| "I want peptides or an aromatase inhibitor alongside therapy." | Marek Health or Opt Health (alphabetical) | Both prescribe well beyond testosterone. Maximus is organized around named protocols rather than an open prescription list. |
| "I want to keep my own testosterone production but Maximus is not available to me." | Marek Health or Opt Health (alphabetical) | Both can prescribe fertility-preserving options case by case, including HCG alongside testosterone. That is a different mechanism from enclomiphene and worth discussing with the prescriber. |
| "My testosterone is fine and I still feel flat." | Function Health, or your own physician | Thyroid dysfunction, iron deficiency, sleep apnea, and depression produce the same symptoms. A protocol-specific platform is not built to separate them. |
| "I want the cheapest way to find out if I am a candidate." | Hone Health, or your own physician | Hone Health starts near $45 a month for the test and a clinician read on candidacy. A primary care visit with morning testosterone, SHBG, LH, and FSH often costs a copay. |
What is not a real Maximus alternative
- Enclomiphene bought without a prescriber. Products sold outside a clinical relationship carry no baseline labs, no monitoring, and no verified content. Enclomiphene affects the same feedback loop a prescriber is meant to be watching.
- A testosterone-boosting supplement. Over-the-counter formulas are not prescription therapy and are not monitored. A claim of meaningful testosterone elevation without a prescription and without labs is unverified.
- Another platform with the same eligibility limit. If high LH ruled out enclomiphene at Maximus, it rules it out everywhere, because the constraint is physiological rather than commercial.
- A fertility supplement stack. If preserving fertility is the goal, a semen analysis measures it and a supplement does not. Order the measurement before buying anything intended to protect the outcome.
What switching actually costs
Budget one duplicate panel. Most prescribers want a baseline drawn through their own lab before writing, even on a recent result, because assay differences between labs are large enough to move a hormone dosing decision.
Do not stop a protocol to make a switch tidy. Enclomiphene and exogenous testosterone act in opposite directions on the same feedback loop, so moving between them is a clinical decision that needs a prescriber managing it against current labs. Raise the plan with the current clinician before you cancel, and keep the membership active until the incoming one has a baseline in hand.
Frequently Asked Questions
What is the best alternative to Maximus?
No platform on this list matches Maximus on its defining feature, since enclomiphene as a standard protocol option is uncommon in telehealth hormone care. The nearest substitutes work differently. Marek Health and Opt Health are both physician-led and can consider fertility-preserving approaches case by case, including HCG prescribed alongside testosterone. Hone Health is the cheaper option when preserving fertility is not a constraint. If fertility is the actual question, a urologist can order a semen analysis, which measures the outcome directly rather than inferring it from hormone levels.
Is there a cheaper alternative to Maximus?
Hone Health is the cheapest entry point among the platforms here, starting near $45 a month for the at-home test and membership, rising to $150 to $220 or more monthly on an active protocol. Maximus protocols run $150 to $300 or more monthly with the initial assessment and labs usually billed separately, landing near $2,000 to $4,000 in year one. A primary care workup is cheaper again if insurance covers the draw, though many physicians decline to manage therapy they do not routinely prescribe.
Why do men switch away from Maximus?
Two reasons dominate. The first is eligibility: enclomiphene works by signalling the testes to produce more testosterone, so it needs testes that can respond. In primary hypogonadism, where LH is already high because the pituitary is signalling hard and the testes are not answering, the mechanism has little to work with. The second is scope. Maximus is hormone-first and organized around named protocols, so it does not cover the broader biomarker panel, metabolic work, or peptide and GLP-1 breadth that a full optimization program offers.
Which alternative also preserves fertility?
Marek Health and Opt Health can both prescribe fertility-preserving approaches case by case, most commonly HCG alongside testosterone. HCG mimics LH at the testes, which is a different mechanism from enclomiphene, and it is prescribed as a clinical judgement rather than sold as a named protocol. Hone Health lists enclomiphene and HCG as options that must be requested rather than defaults. Whether any of these fits a specific case is a question for the prescribing clinician, and a baseline LH and FSH measurement is what informs it.
Does a broader panel matter if I only want hormones treated?
It matters before treatment starts and less afterwards. Flat energy, low libido, and poor recovery are produced by untreated sleep apnea, iron deficiency, hypothyroidism, and depression as readily as by low testosterone, and a protocol-specific panel is not designed to separate them. Once low testosterone is confirmed and the alternatives are ruled out, a narrow panel monitors therapy adequately and costs less. The sequence is what matters rather than the panel size.
Can I move from enclomiphene to testosterone therapy later?
That is a clinical decision for the prescribing clinician rather than a switch you make by changing platforms. The two treatments work in opposite directions on the same feedback loop: enclomiphene raises the body's own signalling, and exogenous testosterone suppresses it. Any change of direction needs a prescriber managing it against current labs. Raise it with the clinician you are already working with before you cancel anything, since the platforms that prescribe testosterone directly will want their own baseline draw regardless.
What should I export before switching?
Every panel, with the name of the lab that ran it, plus the protocol history including what was prescribed and at what dose. Assay and reference-interval differences between labs are large enough to shift hormone values on the same blood, so an incoming prescriber needs to know which lab produced each number. Expect one duplicate baseline panel regardless, because most clinicians want their own before writing a prescription.